The Stock Exchange of Hong Kong Limited, a wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited (HKEx), announces that with effect from 12 July 2011 (Tuesday), Shanghai Pharmaceuticals Holding Co Ltd (Stock code: 2607) and Glencore International plc (Stock code: 805) will be admitted to the list of designated securities eligible for short selling.
The latest list of all designated securities eligible for short selling is available on the HKEx website.